Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AbbVie
Biotech
Reata, Kyowa Kirin ax bardoxolone, ending 13-year saga
Reata and Kyowa Kirin gave bardoxolone the old college try, but ultimately decided to end development after a new late-stage failure.
Max Bayer
May 10, 2023 10:22am
Merck battled 2 other Big Pharmas in pursuit of Prometheus
May 2, 2023 10:55am
BMS CEO set to leave after 8-year run—Chutes & Ladders
Apr 28, 2023 9:30am
AbbVie closes cystic fibrosis chapter after combo 'did not work'
Apr 27, 2023 11:32am
Bausch + Lomb exec to depart—Chutes & Ladders
Apr 14, 2023 9:30am
AbbVie knocks down earnings forecast due to IPR&D charge
Apr 6, 2023 11:10am
